神经Y和衍生品尚未准备好在前列腺癌早期检测中首次使用

相关实验视频

Updated: Jun 20, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.8K

Jonathan Maurer1, Philippe J Eugster1, Kiana Collins2

  • 1Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

European urology open science
|July 19, 2024
PubMed
概括

与前列腺特异性抗原 (PSA) 相比,神经Y (NPY) 不能改善前列腺癌的诊断. 虽然NPY在边界病例中可能提供有限的益处,但目前的证据不支持其作为独立或联合诊断生物标志物的使用.

关键词:
生物标志物生物标志物诊断 诊断 诊断 诊断 诊断神经酸Y 神经酸Y亲神经酸Y是一种神经酸Y.前列腺癌是什么意思 前列腺癌是什么意思前列腺特异性抗原前列腺特异性抗原定量光谱测量是一种量化测量.

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K